Dados B3 › JFEN3 × AMER3
JFEN3 × AMER3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | JFEN3 | AMER3 | year |
|---|---|---|---|
| ROE | -478.8%! | -6.9% | 2019 |
| ROIC | -111.3%! | 3.4% | 2025 |
| ROA | -27.9% | -1.6% | 2025 |
| Gross margin | -33.7% | 27.0% | 2025 |
| EBIT margin | -109.7%! | 2.7% | 2025 |
| Net margin | -127.8% | -2.2% | 2025 |
| Net debt/EBITDA | 19.28x | 4.53x | 2013 |
| Current ratio | 1.02x | 1.67x | 2025 |
| Revenue growth (1y) | 4.8% | -1.2% | 2025 |
| Revenue growth (5y CAGR) | 43.3% | 4.0% | 2025 |
| Piotroski F-Score | 2/9 | 3/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | JFEN3 | AMER3 | year |
|---|---|---|---|
| P/E | -0.04x | -3.81x | 2025 |
| P/B | — | 0.22x | 2025 |
| EV/EBITDA | — | 1.73x | 2025 |
| FCF yield | — | 34.5% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:47 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:47 UTC. If this does not match /saude, you are reading a cached copy.